IntrinsicIntrinsic
← Scroll for more →

Financial Statements — ESSID

Balance Sheet

(in millions USD)
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q4 2021Q3 2021Q2 2021Q1 2021
Cash & Equivalents0.020.010.030.000.000.000.000.000.000.000.000.000.000.000.000.00
Accounts Receivable0.00------------------------0.010.020.01
Total Current Assets0.020.020.070.000.000.000.010.000.000.000.000.000.000.060.060.06
Property, Plant & Equipment----------------------------0.000.00
Intangible Assets0.090.090.100.100.100.100.100.100.100.100.100.10--------
Total Non-current Assets*0.090.090.100.100.100.100.100.100.100.100.100.100.000.000.000.00
Total Assets0.110.120.170.100.100.100.110.100.100.100.100.100.000.060.060.06
Accounts Payable1.020.940.894.704.634.544.674.564.444.334.204.113.183.612.942.86
Total Current Liabilities1.671.431.2417.4517.2016.9416.6716.3816.1115.8615.5615.2810.6512.6111.7411.47
Total Non-current Liabilities*0.000.000.000.000.000.000.000.000.000.000.000.000.350.000.000.00
Total Liabilities1.671.431.2417.4517.2016.9416.6716.3816.1115.8615.5615.2811.0012.6111.7411.47
Retained Earnings(69.78)(69.53)(69.28)(79.51)(79.26)(79.00)(78.73)(78.44)(78.17)(77.92)(77.62)(77.34)(73.15)(74.35)(73.48)(73.22)
Total Stockholder Equity(1.57)(1.31)(1.07)(17.34)(17.10)(16.84)(16.56)(16.28)(16.00)(15.76)(15.46)(15.18)(10.99)(12.55)(11.68)(11.42)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q4 2021Q3 2021Q2 2021Q1 2021
Total Revenue0.000.000.000.000.000.000.000.000.000.000.000.00-0.000.020.020.02
Cost of Revenue------0.000.000.000.000.000.000.000.000.000.010.010.010.01
Gross Profit------0.000.000.000.000.000.000.000.000.00(0.01)0.000.000.01
Research & Development0.080.060.050.070.080.100.080.090.080.080.080.110.040.040.040.04
Total Operating Expenses0.250.230.240.230.240.250.260.260.230.280.260.280.560.320.210.13
Operating Income(0.25)(0.23)(0.24)(0.23)(0.24)(0.25)(0.26)(0.26)(0.23)(0.28)(0.26)(0.28)--(0.30)(0.19)(0.11)
Interest Expense0.010.010.050.010.010.010.010.010.010.010.010.010.050.060.060.06
Pretax Income*--(0.24)10.22(0.25)--(0.27)--------------------
Tax Provision--0.000.000.00--0.00--------------------
Net Income(0.26)(0.24)10.22(0.25)(0.26)(0.27)(0.28)(0.28)(0.25)(0.29)(0.28)(0.29)1.20(0.87)(0.26)(0.17)
Basic EPS----------------0.00--------------
Diluted EPS(0.01)(0.01)4.380.000.00(0.01)----0.00--------------
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in thousands USD)
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q4 2021Q3 2021Q2 2021Q1 2021
Operating Cash Flow7.72(24.87)(106.81)(98.49)(91.89)(70.59)(104.80)(76.05)(56.16)(82.82)(111.56)(247.12)(17.68)(137.93)(115.61)(117.08)
Investing Cash Flow0.000.00----0.000.000.000.000.000.000.00(100.00)--------
Financing Cash Flow0.000.00137.6097.3093.2969.47103.5275.4059.3482.28111.14349.1217.70142.23113.74116.65
← Scroll for more columns →